— Know what they know.
Not Investment Advice

TIL NASDAQ

Instil Bio, Inc.
1W: +0.7% 1M: -6.1% 3M: -6.5% YTD: -35.9% 1Y: -62.2% 3Y: -12.4% 5Y: -98.4%
$7.22
-0.01 (-0.21%)
 
Weekly Expected Move ±3.8%
$7 $7 $7 $7 $8
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $49.0M mcap · 4M float · 0.368% daily turnover · Short 52% of daily vol

Cash Flow Trends

Operating Cash Flow
-$37M +34.3% ▲
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$37M +44.3% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$4M -6180.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$157M-$223M-$156M-$74M-$71M
Depreciation & Amort.$3M$6M$5M$4M$534K
Stock-Based Comp.$26M$30M$18M$17M$9M
Change in Working Capital$4M-$10M-$9M-$13M-$560K
Other Non-Cash Items$636K$16M$60M$10M$26M
Operating Cash Flow-$122M-$180M-$82M-$56M-$37M
— Investing Activities —
Capital Expenditures-$58M-$85M-$21M-$10M-$10M
Acquisitions (Net)$0$1M$0$0$432K
Investment Purchases-$1.1B-$666M-$301M-$136M-$101M
Investment Sales$691M$865M$362M$199M$136M
Other Investing$0-$1M$2M$866K$0
Investing Cash Flow-$474M$115M$41M$54M$25M
— Financing Activities —
Net Debt Issuance$0$70M$8M$3M$7M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$2M$0$0-$1M-$172K
Financing Cash Flow$393M$72M$8M$2M$7M
Net Change in Cash-$204M$6M-$33M-$61K-$4M
Cash End of Period$38M$44M$11M$11M$7M
Free Cash Flow-$180M-$265M-$103M-$66M-$37M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms